Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Miceli

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Antibodies (Basel, Switzerland)|March 28, 2023
Cutaneous Lymphoma and Antibody-Directed TherapiesAlvise Sernicola, Christian Ciolfi, Paola Miceli, et al.
Hematology Reports|June 26, 2024
Skin Hypopigmentation in Hematology DisordersRoberto Mazzetto, Paola Miceli, Alvise Sernicola, et al.
Dermatology Reports|July 1, 2025
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic reviewElena Pezzolo, Sara Di Leo, Paola Miceli, et al.
Life (Basel, Switzerland)|February 24, 2024
Role of IL-4 and IL-13 in Cutaneous T Cell LymphomaRoberto Mazzetto, Paola Miceli, Jacopo Tartaglia, et al.
Molecular and Clinical Oncology|May 3, 2021
Complete remission of primary cutaneous anaplastic large cell lymphoma after a short course of brentuximab vedotinElisa Milan, Paola Miceli, Alvise Sernicola, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin DisordersAlvise Sernicola, Roberto Mazzetto, Jacopo Tartaglia, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Antibodies (Basel, Switzerland)|March 28, 2023
Cutaneous Lymphoma and Antibody-Directed TherapiesAlvise Sernicola, Christian Ciolfi, Paola Miceli, et al.
Hematology Reports|June 26, 2024
Skin Hypopigmentation in Hematology DisordersRoberto Mazzetto, Paola Miceli, Alvise Sernicola, et al.
Dermatology Reports|July 1, 2025
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic reviewElena Pezzolo, Sara Di Leo, Paola Miceli, et al.
Life (Basel, Switzerland)|February 24, 2024
Role of IL-4 and IL-13 in Cutaneous T Cell LymphomaRoberto Mazzetto, Paola Miceli, Jacopo Tartaglia, et al.
Molecular and Clinical Oncology|May 3, 2021
Complete remission of primary cutaneous anaplastic large cell lymphoma after a short course of brentuximab vedotinElisa Milan, Paola Miceli, Alvise Sernicola, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin DisordersAlvise Sernicola, Roberto Mazzetto, Jacopo Tartaglia, et al.
Pageof 1